ArticleLeukemia & lymphoma2014

Ruxolitinib in clinical practice for therapy of myelofibrosis: single USA center experience following Food and Drug Administration approval.

Holly Geyer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.